These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31985586)

  • 21. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
    Lee JW; Na JO; Kang DY; Lee SY; Lee SM
    Clin Lung Cancer; 2017 Mar; 18(2):198-206. PubMed ID: 27495385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defining Optimal Comorbidity Measures for Patients With Early-Stage Non-small cell lung cancer Treated With Stereotactic Body Radiation Therapy.
    DeWees TA; Nikitas J; Rehman S; Bradley JD; Robinson CG; Roach MC
    Pract Radiat Oncol; 2019 Jan; 9(1):e83-e89. PubMed ID: 30244094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer.
    Downey RJ; Akhurst T; Gonen M; Park B; Rusch V
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1419-27. PubMed ID: 17532932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter analysis of survival and prognostic factors in pathologic stage I non-small-cell lung cancer according to the new 2009 TNM classification.
    León-Atance P; Moreno-Mata N; González-Aragoneses F; Cañizares-Carretero MÁ; García-Jiménez MD; Genovés-Crespo M; Honguero-Martínez AF; Rombolá CA; Simón-Adiego CM; Peñalver-Pascual R
    Arch Bronconeumol; 2011 Sep; 47(9):441-6. PubMed ID: 21676516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early-Stage Non-Small Cell Lung Cancer: Quantitative Imaging Characteristics of (18)F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis.
    Wu J; Aguilera T; Shultz D; Gudur M; Rubin DL; Loo BW; Diehn M; Li R
    Radiology; 2016 Oct; 281(1):270-8. PubMed ID: 27046074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer.
    Chansky K; Sculier JP; Crowley JJ; Giroux D; Van Meerbeeck J; Goldstraw P;
    J Thorac Oncol; 2009 Jul; 4(7):792-801. PubMed ID: 19458556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancer.
    Pellegrino S; Fonti R; Mazziotti E; Piccin L; Mozzillo E; Damiano V; Matano E; De Placido S; Del Vecchio S
    Ann Nucl Med; 2019 Dec; 33(12):937-944. PubMed ID: 31612416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leveraging RSF and PET images for prognosis of multiple myeloma at diagnosis.
    Morvan L; Carlier T; Jamet B; Bailly C; Bodet-Milin C; Moreau P; Kraeber-Bodéré F; Mateus D
    Int J Comput Assist Radiol Surg; 2020 Jan; 15(1):129-139. PubMed ID: 31256359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment
    Satoh Y; Motosugi U; Saito A; Omiya Y; Onishi H
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818794934. PubMed ID: 30222060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-treatment
    Ahn HK; Lee H; Kim SG; Hyun SH
    Clin Radiol; 2019 Jun; 74(6):467-473. PubMed ID: 30898382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of total lesion glycolysis and metabolic active tumor volume in non-small cell lung cancer.
    Vanhove K; Mesotten L; Heylen M; Derwael R; Louis E; Adriaensens P; Thomeer M; Boellaard R
    Cancer Treat Res Commun; 2018; 15():7-12. PubMed ID: 30207286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of cancer antigen -125 for lung adenocarcinoma patients with brain metastasis: A random survival forest prognostic model.
    Wang H; Shen L; Geng J; Wu Y; Xiao H; Zhang F; Si H
    Sci Rep; 2018 Apr; 8(1):5670. PubMed ID: 29618796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival.
    Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):151-9. PubMed ID: 15999056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prediction model for pathologic N2 disease in lung cancer patients with a negative mediastinum by positron emission tomography.
    Farjah F; Lou F; Sima C; Rusch VW; Rizk NP
    J Thorac Oncol; 2013 Sep; 8(9):1170-80. PubMed ID: 23945387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2102-2110.e1. PubMed ID: 28947198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic tumor burden quantified on [
    Lapa P; Oliveiros B; Marques M; Isidoro J; Alves FC; Costa JMN; Costa G; de Lima JP
    Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2169-2178. PubMed ID: 28785842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.
    Satoh Y; Onishi H; Nambu A; Araki T
    Radiology; 2014 Jan; 270(1):275-81. PubMed ID: 24029640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Non-small cell bronchogenic carcinoma in advanced stages: prognostic value of weight loss and clinical implications].
    Gullón J; Fernández R; Rubinos G; Medina A; Suárez I; González I
    Arch Bronconeumol; 2001 Dec; 37(11):477-81. PubMed ID: 11734136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):607-12. PubMed ID: 22104678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.